Satish R Raj Selected Research

Renin

1/2018	Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
2/2016	Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure.
1/2014	Neuronal and hormonal perturbations in postural tachycardia syndrome.
3/2013	Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure.
2/2012	Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes.
6/2008	Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure.
4/2005	Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satish R Raj Research Topics

Disease

26	Postural Orthostatic Tachycardia Syndrome 03/2024 - 04/2005
23	Orthostatic Hypotension (Postural Hypotension) 11/2023 - 03/2006
18	Syncope (Fainting) 01/2023 - 06/2006
14	Vasovagal Syncope 01/2023 - 12/2012
12	Tachycardia (Tachyarrhythmias) 12/2021 - 05/2005
10	Hypertension (High Blood Pressure) 01/2023 - 03/2006
5	Heart Failure 01/2023 - 10/2002
5	Bradycardia 11/2022 - 10/2010
5	Hypovolemia 01/2021 - 04/2005
3	Hypotension (Low Blood Pressure) 10/2021 - 08/2005
3	Insulin Resistance 01/2017 - 10/2014
2	Critical Illness (Critically Ill) 01/2022 - 04/2010
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 08/2017
2	Autonomic Nervous System Diseases (Dysautonomia) 01/2020 - 01/2020
2	Obesity 12/2015 - 10/2014
1	Feminization 04/2024
1	Thyrotoxicosis 02/2023
1	Hemorrhage 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022
1	Cardiomyopathies (Cardiomyopathy) 11/2022
1	Atrial Flutter (Flutter, Atrial) 08/2022
1	Chronic Renal Insufficiency 01/2022
1	Brain Hypoxia (Cerebral Hypoxia) 01/2022
1	Sinus Arrhythmia 01/2021
1	Familial Dysautonomia (Riley Day Syndrome) 01/2021
1	Hyperventilation 01/2021
1	Infections 01/2021
1	Disease Progression 11/2020
1	Shock 11/2020
1	Orthostatic Intolerance 11/2020
1	Pain (Aches) 10/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019

Drug/Important Bio-Agent (IBA)

13	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2023 - 06/2008
9	Midodrine (Midon)FDA LinkGeneric 01/2022 - 12/2012
7	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2023 - 07/2007
7	ReninIBA 01/2018 - 04/2005
6	FludrocortisoneIBA 01/2021 - 06/2006
6	hydroxide ionIBA 11/2020 - 08/2006
5	AutoantibodiesIBA 01/2022 - 02/2014
5	AngiotensinsIBA 01/2018 - 03/2011
4	SodiumIBA 01/2021 - 08/2006
4	AldosteroneIBA 02/2016 - 04/2005
3	Amiodarone (Amiodarona)FDA LinkGeneric 02/2023 - 12/2021
3	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2021 - 11/2010
3	DroxidopaIBA 01/2020 - 01/2018
3	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2020 - 07/2007
3	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 09/2009
3	Adrenergic Agents (Adrenergic Drugs)IBA 12/2019 - 01/2017
3	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2019 - 12/2014
3	Angiotensin IIIBA 02/2016 - 02/2012
2	Estrogens (Estrogen)FDA Link 04/2024 - 09/2012
2	SaltsIBA 01/2021 - 01/2021
2	Vasoconstrictor AgentsIBA 01/2021 - 12/2014
2	VaccinesIBA 01/2020 - 01/2020
2	LigandsIBA 01/2018 - 01/2014
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2017 - 03/2011
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 03/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 10/2015
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2017 - 03/2011
2	MineralocorticoidsIBA 02/2016 - 03/2008
2	Insulin (Novolin)FDA Link 10/2015 - 10/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2014 - 02/2013
2	Sildenafil Citrate (Viagra)FDA Link 12/2014 - 06/2008
2	Neurotransmitter Agents (Neurotransmitter)IBA 02/2014 - 03/2011
2	Caffeine (No Doz)FDA LinkGeneric 01/2014 - 03/2011
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2024
1	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2023
1	AntidotesIBA 01/2023
1	Acid Sensing Ion ChannelsIBA 12/2022
1	Ion Channels (Ion Channel)IBA 12/2022
1	Epithelial Sodium ChannelsIBA 12/2022
1	ElectrolytesIBA 11/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Cholinergic ReceptorsIBA 08/2021
1	AntibodiesIBA 08/2021
1	Domperidone (Domperidon)IBA 01/2021
1	CatecholaminesIBA 01/2021
1	Dietary SodiumIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2019
1	Carticaine (Articaine)IBA 10/2019
1	Procaine (Novocaine)FDA LinkGeneric 10/2019
1	Local AnestheticsIBA 10/2019
1	Mepivacaine (Carbocaine)FDA LinkGeneric 10/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 10/2019
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 10/2019
1	empagliflozinIBA 01/2019

Therapy/Procedure

17	Therapeutics 04/2024 - 04/2006
2	Electric Countershock (Cardioversion) 08/2022 - 12/2021
2	Drug Therapy (Chemotherapy) 12/2018 - 03/2010
1	Lower Body Negative Pressure 03/2024
1	Liver Transplantation 01/2023
1	Contraindications 01/2023
1	Aftercare (After-Treatment) 01/2021
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2020